NovaBay Pharmaceuticals, Inc. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending September 30, 2022 was -23.03% (a -353.36% decrease compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -140.01%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 19.49% (a -249.58% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was -13.03% (a -48.4% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was -25.25% (a 51.29% increase from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending September 30, 2022 was 16.47% (a -30.24% decrease compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -7.37% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
16.47% 23.61% 25.75% 17.78%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of NovaBay Pharmaceuticals, Inc.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof NBY including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -23.03% 9.09% 34.98%
2021 57.56% 1.54% 15.76% 1.06% 19.49%
2020 -16.03% 24.12% 6.11% -44.76% -13.03%
2019 -28.95% -37.1% -36.98% 2.35% -25.25%
2018 -2.35% -18.42% -15.14% -26.51% -16.69%
2017 -6.65% 13.76% 23.28% 41.48% 17.34%
2016 -15.52% 4.52% -2.61% 39.16% 2.78%
2015 124.07% 146.78% 157.53% 103.04% 131.93%
2014 124.55% 25.31% -19.17% 9.49% 26.01%
2013 -33.88% 23.58% 49.49% 1.23% 6.14%
2012 22.08% 12.49% 3.79% 1.72% 10.02%
2011 37.9% -3.98%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology